RETRACTED: A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells (Q39647630)

From Wikidata

Jump to navigation Jump to search

retracted scientific article published on January 2011

Language	Label	Description	Also known as
English	RETRACTED: A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells	retracted scientific article published on January 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

RETRACTED: A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Pei-Pei Kung

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Shinji Yamazaki

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Marlena Walls

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Andrea Shen

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Leslie Nguyen

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Gerrit Los

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Tod Smeal

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Min-Jean Yin

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Pramod P. Mehta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926183

28 July 2024

Michael R. Gehring

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926183

28 July 2024

language of work or name

0 references

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0304383510004246?httpAccept=text/xml

1 reference

10.1016/J.CANLET.2010.09.002

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.002

28 July 2024

https://api.elsevier.com/content/article/PII:S0304383510004246?httpAccept=text/plain

1 reference

10.1016/J.CANLET.2010.09.002

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.002

28 July 2024

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

300

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

30-39

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Hsp90: an emerging target for breast cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Heat-shock protein hsp90 governs the activity of pp60v-src kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Mutations of the BRAF gene in human cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Hsp70 and Hsp90--a relay team for protein folding

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

HSP90 and the chaperoning of cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Regulation of Raf-1 by direct feedback phosphorylation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Oncogenic BRAF is required for tumor growth and maintenance in melanoma models

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (hsp90) molecular chaperone

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

PI3K/Akt: getting it right matters

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

The raf inhibitor paradox: unexpected consequences of targeted drugs.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

V599EB-RAF is an oncogene in melanocytes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2010.09.002

Identifiers

10.1016/J.CANLET.2010.09.002

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39647630&oldid=2214552998"